# Haresh Selvaskandan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/haresh-selvaskandan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,158 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 19 |
| i10-index | 28 |
| Last Known Institution | University of Leicester |
| OpenAlex ID | https://openalex.org/A5060496810 |
| ORCID iD | 0000-0002-2874-7005 |
| Works | 67 |

## Researcher papers

- [Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/azithromycin-in-patients-admitted-to-hospital-with-covid-19-recovery-a/)
- [Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-sparsentan-versus-irbesartan-in-patients-with-iga/)
- [Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial](https://scholariq.org/papers/sparsentan-in-patients-with-iga-nephropathy-a-prespecified-interim-analysis-from/)
- [The pathogenesis of IgA nephropathy and implications for treatment](https://scholariq.org/papers/the-pathogenesis-of-iga-nephropathy-and-implications-for-treatment/)
- [Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients](https://scholariq.org/papers/neutralising-antibodies-after-covid-19-vaccination-in-uk-haemodialysis-patients/)
- [New strategies and perspectives on managing IgA nephropathy](https://scholariq.org/papers/new-strategies-and-perspectives-on-managing-iga-nephropathy/)
- [Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management](https://scholariq.org/papers/monitoring-immune-responses-in-iga-nephropathy-biomarkers-to-guide-management/)
- [Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort](https://scholariq.org/papers/effects-of-rare-kidney-diseases-on-kidney-failure-a-longitudinal-analysis-of-the/)
- [Immunological drivers of IgA nephropathy: Exploring the mucosa–kidney link](https://scholariq.org/papers/immunological-drivers-of-iga-nephropathy-exploring-the-mucosa-kidney-link/)
- [Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms](https://scholariq.org/papers/seroprevalence-of-antibody-to-s1-spike-protein-following-vaccination-against/)
- [New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy](https://scholariq.org/papers/new-insights-into-the-pathogenesis-and-treatment-strategies-in-iga-nephropathy/)
- [IgA nephropathy: an overview of drug treatments in clinical trials](https://scholariq.org/papers/iga-nephropathy-an-overview-of-drug-treatments-in-clinical-trials/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [University of Leicester](https://scholariq.org/institutions/university-of-leicester/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.